Key Highlights

Risk & Performance

Pipeline Risk Assessment

Pipeline Risk Assessment

Based on historical performance

Moderate Risk

Score: 45/100

Failure Rate

0.0%

0 terminated/withdrawn out of 5 trials

Success Rate

100.0%

+13.5% vs industry average

Late-Stage Pipeline

0%

0 trials in Phase 3/4

Results Transparency

0%

0 of 2 completed trials have results

Key Signals

2 recruiting

Enrollment Performance

Analytics

No phase data available

Activity Timeline

Global Presence

Loading network data...

Clinical Trials (5)

Showing 5 of 5 trials
NCT05800925Recruiting

Triage Survey for Psychiatry Research Eligibility

Role: lead

NCT06104852Recruiting

Triage Survey for Neurology Research Eligibility

Role: lead

NCT04748276Unknown

Tracking Response to Antidepressants in Advance of Investigational Trials

Role: lead

NCT05025670Completed

Tracking Response in Advance of Investigational Trials, Borderline Study

Role: lead

NCT04933630Completed

Tracking Response to Antidepressants in Advance of Investigational Trials, Relapse Study

Role: lead

All 5 trials loaded